SOHO 2023 | IPPS-M: incorporating genomic data into the IPPS criteria for MDS
In this video, Uwe Platzbecker, MD, University of Leipzig, Leipzig, Germany, discusses the importance of incorporating genomic data in the diagnostic work-up of patients with myelodysplastic syndromes (MDS), highlighting the Molecular International Prognostic Scoring System (IPSS-M). Prof. Platzbecker also addresses challenges associated with the accessibility of this tool. This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Grant support, paid to GWT-TUD, from Amgen; lecture fees and grant support, paid to the University of Leipzig, from Amgen; fees for serving on a steering committee, consulting fees, and travel support from Bristol Myers Squibb; grant support, paid to GWT-TUD, from Janssen Biotech; grant support, paid to University Dresden, from Merck and Novartis; lecture and consulting fees from Novartis; and consulting fees from AbbVie, Curis, and Geron.
